(NYSE: ATR) Aptargroup's forecast annual revenue growth rate of 4.71% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.3%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.21%.
Aptargroup's revenue in 2025 is $3,610,693,000.On average, 10 Wall Street analysts forecast ATR's revenue for 2025 to be $246,129,630,192, with the lowest ATR revenue forecast at $234,995,821,974, and the highest ATR revenue forecast at $257,790,482,586. On average, 10 Wall Street analysts forecast ATR's revenue for 2026 to be $258,054,004,674, with the lowest ATR revenue forecast at $243,494,409,312, and the highest ATR revenue forecast at $275,248,820,916.
In 2027, ATR is forecast to generate $274,392,374,130 in revenue, with the lowest revenue forecast at $256,604,633,190 and the highest revenue forecast at $291,784,831,938.